- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tempest Therapeutics Inc (TPST)
Track the Tempest Therapeutics share price today and view real-time TPST share price data, including charts, technicals, and key financials. View the TPST premarket stock price ahead of the market session or assess the after hours quote. Explore TPST stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the Tempest Therapeutics Stock Price Today?
The Tempest Therapeutics stock price today is 0.8290.
What Is the Stock Symbol for Tempest Therapeutics?
The stock symbol for Tempest Therapeutics is ""TPST.""
What Stock Exchange Does Tempest Therapeutics Trade On?
Tempest Therapeutics is listed and trades on the NASDAQ stock exchange.
Is Tempest Therapeutics a Good Stock to Buy?
Determining whether Tempest Therapeutics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TPST quote. (ISIN: US87978U2078)
What Is the Tempest Therapeutics Stock Price Today?
The Tempest Therapeutics stock price today is 0.8290.
What Is the Stock Symbol for Tempest Therapeutics?
The stock symbol for Tempest Therapeutics is ""TPST.""
What Stock Exchange Does Tempest Therapeutics Trade On?
Tempest Therapeutics is listed and trades on the NASDAQ stock exchange.
Is Tempest Therapeutics a Good Stock to Buy?
Determining whether Tempest Therapeutics or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TPST quote. (ISIN: US87978U2078)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8150
0.8946
52 wk Range
0.7432
12.2300
TPST is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.81500.8946
52 wk Range
0.743212.2300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
TPST Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.0000
Upside
+744.39%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Form 8K Tempest Therapeutics Inc For: 15 September- Investing.com
- Form 8K Tempest Therapeutics Inc For: 17 September
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.0000
(+744.39% Upside)
Earnings
Latest Release
13/08/2026
EPS / Forecast
-0.34 / -0.30
Revenue / Forecast
-- / --
Compare TPST to Peers and Sector
Metrics to compare | TPST | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTPSTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −2.0x | −0.4x | |
PEG Ratio | −0.01 | −0.02 | 0.00 | |
Price/Book | −12.6x | 3.6x | 2.6x | |
Price / LTM Sales | - | 97.0x | 3.0x | |
Upside (Analyst Target) | - | 118.1% | 58.0% | |
Fair Value Upside | Unlock | 20.7% | 8.0% | Unlock |
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma that completed Phase 2 clinical trial; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study; and has a product development and investigator-initiated trial collaboration agreement with Heibei Senlang Biotechnology Co., Ltd. to develop TPST-4003 product candidate. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Tempest Therapeutics (TPST) Stock Price Today?
The Tempest Therapeutics stock price today is 0.8290 USD.
What Stock Exchange Does Tempest Therapeutics Trade On?
Tempest Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Tempest Therapeutics?
The stock symbol for Tempest Therapeutics is "TPST."
What Is the Tempest Therapeutics Market Cap?
As of today, Tempest Therapeutics market cap is 14.0600M USD.
What Is Tempest Therapeutics's Earnings Per Share (TTM)?
The Tempest Therapeutics EPS (TTM) is -4.5557.
When Is the Next Tempest Therapeutics Earnings Date?
Tempest Therapeutics will release its next earnings report on 11/11/2026.
From a Technical Analysis Perspective, Is TPST a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Tempest Therapeutics Stock Split?
Tempest Therapeutics has split 3 times.
How Many Employees Does Tempest Therapeutics Have?
Tempest Therapeutics has 4 employees.
What is the current trading status of Tempest Therapeutics (TPST)?
As of 26/09/2026, Tempest Therapeutics (TPST) is trading at a price of 0.8290 USD, with a previous close of 0.8290 USD. The stock has fluctuated within a day range of 0.8150 USD to 0.8946 USD, while its 52-week range spans from 0.7432 USD to 12.2300 USD.
What Is Tempest Therapeutics (TPST) Price Target According to Analysts?
The average 12-month price target for Tempest Therapeutics is 7.0000 USD, with a high estimate of 7 USD and a low estimate of 7 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +744.39% Upside potential.
What Is the TPST Premarket Price?
TPST's last pre-market stock price is 0.8620 USD. The pre-market share volume is 13,390.0000, and the stock has decreased by 0.0120, or 1.4100%.
What Is the TPST After Hours Price?
TPST's last after hours stock price is 0.8225 USD, the stock has decreased by -0.0065, or -0.7800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.